Interactive Strength (TRNR) shares soared 31% after the company unveiled Tuesday CLMBR fitness equipment installations in Saudi Arabia.
More than 24.4 million shares traded intraday compared with a daily average of about 146,000.
Piper Sandler upgraded Aclaris Therapeutics (ACRS) to overweight with a price target of $13.
The move comes as Aclaris said it acquired global development rights outside of China for potential anti-TSLP monoclonal and bispecific antibodies directed against both TSLP and IL4R developed by Chinese biotech firm Biosion.
Shares of Aclaris catapulted 50% as intraday trading volume soared to more than 48.4 million from a daily average of about 1.03 million.
Invizyne Technologies (IZTC) said Tuesday that it received a $2 million project to enable enzyme production for cell-free biomanufacturing of sustainable aviation fuel.
Shares jumped 12%, with intraday trading volume at over 10,400 compared with a daily average of about 45,000.
Price: 3.31, Change: +0.78, Percent Change: +30.83
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。